Estimations des analystes de Wall Street pour DBV Technologies S.A. (DBVT): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-10-28 | $-0.16 | ||
| 2026-07-16 | $-0.14 | $-0.12 | -14.4% |
| 2026-04-30 | $-0.56 | $-0.14 | -300.0% |
| 2026-03-27 | $-1.15 | $-1.30 | +11.5% |
| 2025-10-28 | $-0.34 | $-1.45 | +76.3% |
| 2025-07-30 | $-1.55 | $-0.21 | -638.1% |
| 2025-04-30 | $-0.26 | $-0.24 | -8.3% |
| 2025-03-24 | $-0.26 | $-0.31 | +16.2% |
Ratios de valorisation
| Prix / Valeur comptable | 5.75 |
| EV / EBITDA | -1.56 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $7.9M | $11.5M | $12.8M | $14.7M | $11.3M | $5.7M | $4.8M | $15.7M | 0 | 0 |
| Coût des Ventes | $1.4M | $3.4M | $5.0M | 0 | 0 | $10.4M | 0 | 0 | $6.8M | 0 |
| Marge Brute | $7.9M | $11.5M | $12.8M | $14.7M | $11.3M | -$4.7M | $4.8M | $15.7M | -$6.8M | 0 |
| R&D | $82.9M | $126.3M | $123.5M | $112.2M | $101.6M | $70.3M | $75.5M | $60.2M | $89.9M | $116.7M |
| Frais Généraux | $48.5M | $61.5M | $82.2M | $70.7M | $45.0M | $23.8M | $25.9M | $31.9M | $23.8M | $36.0M |
| Charges Opérationnelles | $128.0M | $185.5M | $203.2M | $192.8M | $170.1M | $93.9M | $101.5M | $92.2M | $113.7M | $147.1M |
| Résultat Opérationnel | -$122.1M | -$173.9M | -$190.1M | -$171.0M | -$158.8M | -$98.6M | -$96.6M | -$76.4M | -$120.5M | -$147.1M |
| EBITDA | -$126.3M | -$176.9M | -$206.2M | -$168.4M | -$124.8M | -$91.2M | -$83.5M | -$63.3M | -$111.0M | -$139.3M |
| Charges d'Intérêt | $17650 | $4.0M | $479764 | $377929 | $724000 | $690000 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$126.3M | -$177.1M | -$190.2M | -$171.4M | $159.6M | -$98.2M | -$96.2M | -$72.7M | -$117.8M | -$146.5M |
| Impôts | $1.7M | $1199 | $17158 | $610000 | $10000 | -$381000 | $70000 | $7000 | -$4.1M | $491000 |
| Résultat Net | -$126.3M | -$177.2M | -$190.3M | -$172.0M | -$159.6M | -$97.8M | -$96.3M | -$72.7M | -$113.7M | -$146.9M |
| BPA | $-4.70 | $-5.95 | $-3.05 | $-2.90 | $-2.95 | $-1.80 | $-1.25 | $-0.75 | $-1.20 | $-1.70 |
| BPA Dilué | $-4.70 | $-5.95 | $-3.05 | $-2.90 | $-2.95 | $-1.80 | $-1.25 | $-0.75 | $-1.20 | $-1.70 |
| Actions en Circulation (Diluées) | $24.5M | $24.8M | $54.9M | $53.3M | $54.1M | $55.1M | $77.4M | $95.1M | $96.2M | $86.4M |
Prix
| Prix | $11.79 |
| Capitalisation | $282M |
| Bourse | NASDAQ |
| Pays | FR |
Entreprises liées: ALT · AMRN · ANNX · ANRO · CLLS · ENGN · KRRO
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de DBVT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions